RxSight, Inc. Announces Transition of Chief Financial Officer Shelley Thunen

ALISO VIEJO, Calif.—RxSight, Inc., an ophthalmic medical device company dedicated to providing customized vision options to patients following cataract surgery, has announced that Shelley Thunen, the company’s chief financial officer, is transitioning from her role. Thunen will remain with the company until her successor is appointed or until January 31, 2026, whichever occurs first, the announcement said. RxSight also advised that Thunen has agreed to support the company as a consultant subsequent to the transition.